NUTRA PHARMA CORP Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Nutra Pharma Corp quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2022.
  • Nutra Pharma Corp Common Stock, Shares, Issued for the quarter ending September 30, 2022 was 7.6B shares, a 3.95% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 7.6B +288M +3.95% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 7.59B +319M +4.39% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 7.36B +139M +1.92% Mar 31, 2022 10-Q 2022-05-20
Q4 2021 7.33B +376M +5.4% Dec 31, 2021 10-Q 2022-11-21
Q3 2021 7.31B +563M +8.34% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 7.27B +640M +9.65% Jun 30, 2021 10-Q 2021-09-24
Q1 2021 7.23B +603M +9.1% Mar 31, 2021 10-Q 2021-09-17
Q4 2020 6.96B +1.08B +18.4% Dec 31, 2020 10-K 2022-04-15
Q3 2020 6.75B +1.67B +32.9% Sep 30, 2020 10-Q 2021-08-12
Q2 2020 6.63B +1.59B +31.5% Jun 30, 2020 10-Q 2021-08-05
Q1 2020 6.62B +2.5B +60.4% Mar 31, 2020 10-Q 2021-07-23
Q4 2019 5.88B +1.83B +45.2% Dec 31, 2019 10-K 2021-09-08
Q3 2019 5.08B +1.06B +26.5% Sep 30, 2019 10-Q 2021-05-14
Q2 2019 5.04B +1.8B +55.5% Jun 30, 2019 10-Q 2021-05-07
Q1 2019 4.13B +1.8B +77% Mar 31, 2019 10-Q 2021-04-05
Q4 2018 4.05B +2.01B +99.1% Dec 31, 2018 10-K 2021-07-01
Q3 2018 4.01B +2.28B +131% Sep 30, 2018 10-Q 2018-11-19
Q2 2018 3.24B +2.41B +288% Jun 30, 2018 10-Q 2018-08-17
Q1 2018 2.33B +1.96B +533% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 2.03B +1.03B +103% Dec 31, 2017 10-K 2021-02-05
Q3 2017 1.73B +1.51B +660% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 835M +687M +466% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 368M +262M +247% Mar 31, 2017 10-Q 2017-05-17
Q4 2016 1B +920M +1154% Dec 31, 2016 10-Q 2022-11-21
Q3 2016 228M +157M +220% Sep 30, 2016 10-Q 2016-11-22
Q2 2016 147M +98.8M +204% Jun 30, 2016 10-Q 2016-08-22
Q1 2016 106M +67.1M +171% Mar 31, 2016 10-Q/A 2016-06-21
Q4 2015 79.8M +43M +117% Dec 31, 2015 10-K 2017-04-17
Q3 2015 71.4M -933M -92.9% Sep 30, 2015 10-Q 2015-11-23
Q2 2015 48.6M -1.22B -96.2% Jun 30, 2015 10-Q 2015-08-18
Q1 2015 39.1M -1.02B -96.3% Mar 31, 2015 10-Q 2015-05-19
Q4 2014 36.8M -968M -96.3% Dec 31, 2014 10-K 2016-04-14
Q3 2014 1B +79.2M +8.57% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 1.27B +556M +78.1% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 1.06B +473M +80.2% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 1B +443M +78.8% Dec 31, 2013 10-K 2015-04-13
Q3 2013 925M +537M +138% Sep 30, 2013 10-Q 2013-11-19
Q2 2013 712M +327M +84.9% Jun 30, 2013 10-Q 2013-08-19
Q1 2013 589M +214M +57% Mar 31, 2013 10-Q 2013-05-20
Q4 2012 562M +241M +75% Dec 31, 2012 10-K 2014-03-31
Q3 2012 388M +83.1M +27.2% Sep 30, 2012 10-Q/A 2012-12-12
Q2 2012 385M +88.1M +29.6% Jun 30, 2012 10-Q/A 2012-12-07
Q1 2012 375M Mar 31, 2012 10-Q/A 2012-11-28
Q4 2011 321M +40.9M +14.6% Dec 31, 2011 10-K 2013-04-16
Q3 2011 305M Sep 30, 2011 10-Q 2011-11-15
Q2 2011 297M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 280M Dec 31, 2010 10-K/A 2012-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.